Navigation Links
Stem Cell Assurance Announces Appointment of Mark Weinreb, M.S. as Chief Executive Officer and Board Member
Date:10/19/2010

BOCA RATON, Fla., Oct. 19 /PRNewswire-FirstCall/ -- Stem Cell Assurance, Inc. (Pink Sheets: SCLZ) announced today the appointment of Mark Weinreb as Chief Executive Officer and as a member of the Company's Board of Directors.  Mr. Weinreb is a well-recognized and respected professional within the medical and financial communities.

Mr. Weinreb offers expertise in public (President and CEO of AMEX and NASDAQ listed companies) and private corporate management, in the areas of healthcare, medical devices, research programs, franchising, and business/product development. Mr. Weinreb was most recently President and a director of NeoStem, Inc., a public biotechnology medical services company specializing in enhancing the delivery of adult stem cell therapeutics and developing an international network of adult stem cell collection centers.

Mr. Weinreb also was an owner and operator of BioHealth Laboratories, Inc., a leading diagnostic state-of-the-art medical laboratory providing clinical testing services for physicians, hospitals, and other medical laboratories.  He was educated at Northwestern University and C.W. Post (Long Island University).

Gloria McConnell, President of Stem Cell Assurance, stated, "We are extremely pleased and fortunate to have a seasoned entrepreneur and executive of Mr. Weinreb's caliber become so excited about our Company that he has accepted our offer to become our full time chief executive officer and provide his leadership skills in growing the Company's business."  

Said Mr. Weinreb, "I believe the Company's business has tremendous potential, and I very much look forward to embarking on an aggressive growth strategy that will position the Company to capitalize on current and future therapeutic uses of adult stem cells."

About Stem Cell Assurance, Inc.

Stem Cell Assurance, Inc.'s goal is to become a medical center of excellence using cell and tissue regenerative therapy protocols, primarily involving a patient's own (autologous) adult stem cells (non-embryonic), allowing patients to undergo cellular-based treatments. As more and more cellular therapies become standard of care, the Company believes its strength will be its focus on the unity of medical and scientific explanations for its future clinical procedures and outcomes and its incorporation of adult stem cell collection and storage services for future personal medical applications. The Company intends to offer, through its "Lipo Rejuvenation Centers," the collection of adipose tissue for use in cosmetic treatments and for the separation and storage of adult stem cells. The Company also operates a wholly-owned subsidiary, Stem Cellutrition™, which offers and sells facial creams and products.

This press release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events or results to differ materially from those projected in the forward-looking statements as a result of various factors and other risks. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and the Company undertakes no obligation to update such statements.

CONTACT
Gloria McConnell
President
Tel: (561) 362-4142
Fax: (561) 362-4451
E-mail: gloriamcconnell@stemcellassurance.com




'/>"/>
SOURCE Stem Cell Assurance, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Joseph J. Ross, M.D., F.A.C.S. Joins Stem Cell Assurance as Vice Chairman
2. Stem Cell Assurance Unveils Physician Network Offering Regenerative Cell Cosmetic and Reconstructive Applications
3. Sepha's Blue Dye Test Alternative Brings ‘Complete Automation' To Pharma-Packaging Quality Assurance
4. Blue Dye Test Alternative Installed at Bayer China for Packaging Quality Assurance Process
5. Hector Garcia Joins Particle Sciences as Director of Quality Assurance
6. Cytochroma appoints Steven I. Engel as Vice President of Regulatory Affairs and Quality Assurance
7. Lotus Pharmaceuticals Announces New Patent for Controlled-Release Diabetes Drug
8. Questcor Announces Third Quarter 2010 Earnings Release Date and Conference Call
9. Synthetech Announces Bankruptcy Court Approval of Merger With W. R. Grace Subsidiary
10. OncoGenex Pharmaceuticals, Inc. Announces Proposed Public Offering
11. Neurocrine Biosciences Announces Conference Call and Webcast to Report Third Quarter 2010 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/4/2016)... Feb. 4, 2016  CytoSorbents Corporation (NASDAQ: ... its flagship CytoSorb® blood filter to treat deadly ... the world, announced that CEO Dr. Phillip ... Source Capital Group,s 2016 Disruptive Growth & Healthcare ... company.  Conference Presentation Details: ...
(Date:2/4/2016)... -- ContraVir Pharmaceuticals, Inc. (NASDAQ: CTRV ), a ... targeted antiviral therapies, announced today that it will present ... held February 8-9, 2016, at the Waldorf Astoria New ... Healthcare Conference, taking place in New York ... Sapirstein , Chief Executive Officer of ContraVir, will provide ...
(Date:2/4/2016)... ... 04, 2016 , ... Franz Inc. , an early ... has been recognized As “ Best in Semantic Web Technology - USA & ... America, it’s our priority to showcase prominent professionals who are excelling in their ...
(Date:2/3/2016)... SAN DIEGO , Feb. 3, 2016 /PRNewswire/ ... medicine company with the first pluripotent stem cell-derived ... 1 diabetes in clinical-stage development, today announced that ... Janssen Pharmaceutical Companies of Johnson & Johnson, have ... BetaLogics group into ViaCyte.  The agreement provides ViaCyte ...
Breaking Biology Technology:
(Date:1/21/2016)... , January 21, 2016 ... to a new market research report "Emotion Detection and ... Others), Software Tools (Facial Expression, Voice Recognition and ... - Global forecast to 2020", published by MarketsandMarkets, ... expected to reach USD 22.65 Billion by 2020, ...
(Date:1/18/2016)... Calif. , Jan. 18, 2016  Extenua ... software that simplifies the use and access of ... and go-to-market partnership with American Cyber.  ... brings extensive experience leading transformational C4ISR and Cyber ... and integrating the latest proven technology solutions," said ...
(Date:1/11/2016)... 11, 2016 Synaptics Incorporated (NASDAQ: SYNA ... announced that its ClearPad ® TouchView ™ ... two separate categories in the 8 th Annual ... Technology Breakthrough. The Synaptics ® TDDI solution enables ... chain, thinner devices, brighter displays and borderless designs. ...
Breaking Biology News(10 mins):